Start with Real Medication Weve seen a rise in products like Kind Patches claiming to help with weight loss but they dont contain any actual GLP-1 medications like semaglutide or tirzepatide
Semaglutide, liraglutide, tirzepatide, and related incretin therapies are now being studied across cardiovascular risk, kidney outcomes, inflammation, addiction signals, neurobiology, and eye health
These are standard exclusions across all semaglutide programs
Semaglutide and tirzepatide, however, have been compared head-to-head
2,3 Furthermore, several cardiovascular outcome trials (CVOT) suggest GLP-1 RAs confer a mortality benefit, with significant reductions in major adverse cardiovascular events, all-cause mortality, heart failure severity, and worsening kidney function